ABSTRACT. The fattv acid. docosahexaenoic acid (DHA.
TG, triglyceride
BHT, butylated hydroxytoluene SAS, statistical analysis system Both mammalian brain gray matter and retinal membrane ethanolamine phosphoglyceride are enriched highly in docosahexaenoic acid (DHA, 22:6n-3) (1-5), an elongation-desaturation product of linolenic acid (18:3n-3) . In the human infant most accumulation of DHA in these membranes occurs in the last intrauterine trimester (6, 7) . Studies undertaken by Clandinin and coworkers (6, 8, 9) provided evidence that human milk could meet the theoretical needs for brain polyunsaturated fatty acids following premature delivery. A study of red blood cell phospholipids in preterm infants provided evidence that DHA status prior to birth is maintained by maternal/placental transfer, that DHA in human milk does indeed substitute in part for this accumulation, and that preterm infants have a relatively poor ability to convert 18:3n-3 to DHA (2) . Other investigators have raised the question of the ability of the neonate to convert both linoleic (1 8:2n-6) and linolenic (1 8:3n-3) acids to the long-chain polyenoates concentrated in nervous tissue (9, 10) since humans appear to have a limited ability for A4-desaturation ( 1 I), the final catalytic step in the formation of 22:5n-6 and 22:6n-3.
No direct evidence is available to evaluate the degree of I/?
novo synthesis of the 22-carbon polyunsaturates by developing infants. Indirect evidence that A4-desaturation is limited in preterm infants is based on the steady decline in membrane DHA following birth early in the third trimester (2, 3) . Decreases in red blood cell DHA in preterm infants may be indicative of limited DHA accumulation during the period when it normally accumulates in the central nervous system. Studies in the rat show that the DHA content of red blood cell phospholipids is related to those of the central nervous system during development (12) . Poor accumulation of DHA during development has been associated with abnormalities in visual acuity and electroretinograms in the rhesus monkey (13, 14) and electroretinograms (1 5, 16) and behavior ( 1 7, 18) in the rat. DHA may be necessary during a specific developmental period as abnormal electroretinograms in rhesus monkeys and rats, respectively, were not rcvcrscd hq latcr nor-mali~atior~ of' rnc1i1brane I>lI.A nit11 a source ol' (fietar! I l l 1A ( 14. l j ) . I!viclcncc contradicting a I-ole I'or I l l 1A in norrnal vision and retinal response to light has also bccn reported ( 10. 30).
As noted prc\ iously. the small amount of' I11 1.2 in liuman r-nilk (0. I lo 0.3'1; of' total li~tt! acids) ( 3 1. 33) is an import;~rlt source ol'rcti blood cell I)l[A in dcvcloping ~n f a n t s (3. 31). Since many prctcr-ni inlint\ tlo riot I-cccivc huriiar~ rnrlh. a ti511 oil triglyceridc highl> concentrated irl both I>IIA anti l:l'A (Maxl-I'A. I<. 1' . Schcrc~-. '11-04. MI) \+as administcrcd b! or-ogastric tuhc (750 mg/kg/d:~!,). This do\c pr-cventcd the declirlc in red hlood ccll phospholipid IIIIA ( 3 ) uith trcatcd inf:~nts ha\ing rcd blood ccll pho5pIiolipid IIIIA like inli1nt5 k d human milk (3, 3 I ).
J'hc present investigation was ticsigned to d c t e r m~n c i f~r p t a k e of 1)IIA could be irnpro\cd I ?! microdispersion o f fish oil in prctcrrn for-mula and co~lscclucnt adrnrnistration in multiple daily li.edings. O u r hypothesis \\a5 that microdispccrsio~i/r~i~~ltiplL. kcdings woulcl increase uptakc comp:~rcd to bolus lish oil in pretcrm infants. Since pl:~srna phospholipids rapidl! reflect changes in tiietarq li~tty :tcid composition. 1)I~IA uptake \+as assessed hy li~tty acid analysis ofp1:tsrna 1' 1: and PC'. l'rigl>ccr-idc Ii~tty acids were analy/ed also. Inli~nts were fi.d one of' thr-cc fi)rmulas contarning by analysis either 0. 0.2. or 0.55; 111 IA and 0, 0.34, ant1 0 . 8 5 IrI'A bq weight. .l'hc fish oil source of 1)lIA was microd~spcrscd in : I li)rrnula designed for pretcrm infnnts (Sirnilac Special ('arc. Koss I.abor-atorics. ('olurnbus. 011) : I I I~ administered in cight identical daily fixdings (stud!. 3). I h t a from thcsc infants arc contrasted with thosc fiom infr~nts rccei\-ing daily cithcr-0.5 o r 2.0 times the intake of'both EPA and I)t 1A in a single bolus of lish oil (study I ).
L \ '~~i ( l j~~~o~)~r l r i~i o~~.
Infants enrolled in these studies wciglied less than 1500 g at birth (range 560 to 1440 g). All were kcc of'~ii:i~or congenital rnalli~r-mations and disease processes. Most infit~its received respiratory support l i~r a short inter-val pr-ior to cntcring the study with cithcr c o n t i n i r o~~s positive airwa! pressure or intubation and mechanical ventilation. Kcd blood cells were administered as necessary to maintain a hcmatocrit of 40';; in infilnts until they reached 1 500 g. .l'lic i n h n t s were discharged at approximately I XOO g. A total of' 17 infants was rccr-uitcd fhr study 2 in April and Ma! 01' 1086. and all samples wcre collected by mid-June. Most of these patients wcre born in March and April 1986. During thcsc 3 months a total o f 4 4 infants weighing less than 1400 g at birth wcr-c admitted to the intensive care unit and survived. O n e infant enrolled did not complete the 2 ~v k of fccding because of fccding intolerance resulting in remo\al of cntcral fccdings fi)r more than 24 h. This infant rccci\.cd the lower level of fish oil supplementation. Details of the p c r~o d of cnrollmcnt and the ~lurnbcr ofinlilnts enrolled. lost to the study. and available for enrollment during study 1 have bccn published ( 3 ) .
lu~~c~rirnc,r~triI tIc~si,yn. The design of study I has been dcscr-ibed ( 3 ) . Infants in study 2 wcre enrolled aftcr obtaining infbrnlcd conscnt from a parent 3s proved bq the Institutional Review I3oard of the University of' Mississippi Medical Center. Study 2 infants wcrc randomly assigned to receive one of three fi)rrnulas. By calculation from the analysis of the individual components of Similac Special Care and MaxEPA and by gas chromatographic analysis of the sonicatcd fi)rmulas, thcse three formulas contained 0, 0.2, and 0.5% of total fatty acids as DIIA and 0. 0.34, and 0.80% as EPA. respectively. Hlood samples werc drawn at 0 time (enrollment, start 0 1 ' treatment) and aftcr 1. 7. and I4 days. 'l'hc h t t y acid composition of plasma phospholipids (PE. I T ) and 7'(; was analy7cd hy gas chromatography after purification ofeach lipid class and transmethylation off;~tty acids with boron trifluoridc-methanol.
The design of study 2 difTercd fiom study I in that a) all i n l i~~i t s rccei\.eil the identical pl-ctcr-m for-mula (Sirnilac. Spc,i.ial ('a[-c. fioss 1.aho1-ator-ics. ('ol~~rnhuq. 0 1 1 ) ~~l.;ti%acl ol' ;ill! ol sc\ cral 17rctcr.m h)~-rni~l:i\: 11) all ir~l'~nt\ 1-~cc1\ ed I00 ki.al/kg/da! ol' Similac Sl~ecial (':lr-c \\it11 111takc ati,j~~stctl li)r-\\c~gllt y i r i \\cckl! instcad 01'2 I-:ingc 01' ~ritahc\ ( 6 0 to I20 ki.al/Ag/tl:~! ): c.1 the dail! dose of lid1 oil was di5l>cr-\ecl in lilrni~rla 11) i~Iti-a\ouri~i and atiministercti in eight dail! I.cedings instcad ol'oncc tiall! a\ a bolus: ;inti ti) all sti~ci! 3 ir1l~111ts ucrc ~>ro\~dc.tl \\it11 tlail! supplementar-! Litamin F (25 II'. ,\cl~ra\ol I: clr-op\. \I-mour 1'liarmaccutii.al ('o and EPA dctcrmrned in study 2 fi)rrn~~las.
I,Uoorl S(IIII/~/~JS. O n e 1311 of blood was dl-awn from a n arm w i n and added to EDTA to prevent coagul:~tion. I'lasma was rcmo\ed afier centrifugation at 5" C and the red blood cclls washed three times with 3 . This solvent system is a slight modification of that of Zail and Pickering (25) . The procedures used for identification and isolation of the phospholipid bands (PE, PC) have been published, along with details of the preparation of fatty acid methyl esters (26) and their identification and quantitation by gas liquid chromatography (3). Data are expressed here for only plasma PE DHA and EPA, but detailed information of other plasma fatty acids and red blood cell phospholipid (PE, PC, PS) fatty acids (study 2) may be obtained from the authors. Red blood cell phospholipid analysis from study 1 has been published (3).
S/uri.stic,al ana1j:ris. Fatty acids were analyzed following the multivariate analysis of variance approach of Cole and Grizzle (27) with significant treatment differences explored using the student Newman-Keul's multiple range test. For each fatty acid analyzed, significant treatment, time or time x treatment interactions were possible. Calculations were performed on the SAS (28) data package. Furthermore, as with PE DHA, additional significant increases did not occur beyond 2 wk of fish oil administration. By analysis of variance time x treatment interactions for EPA (20:5n-3) and DHA (22:6n-3) were significant in plasma phospholipids (PE, PC, p < 0.Q01) and TG ( p < 0.02).
RESULTS

Bolus orogustric. udtninistrufion ($fish oil ( Y I I I L I~
Other than DHA and EPA. only 22:5n-6 showed a highly significant effect of treatment. Lower values were observed in both PE ( p < 0.0001) and PC ( p < 0.0002) in supplemented compared to unsupplemented infants. After four weeks PE arachidonate (20:4n-6) showed a less significant ( p < 0.04) treatment effect. The weight percent in unsupplemented declined from 17 to 14.2% while in supplemented infants the decline was from 13.4 to 12.2%.
Several fatty acids in phospholipids changed significantly with time (i.e. independent of treatment). In two of the three (PE, PC, T C ) plasma lipid fractions a significant increase in linoleic acid (1 8:2n-6) ( p < 0.001) and decrease in 20:4n-6 ( p < 0.05) occurred with time. In addition, plasma PC 16:0 ( p < 0.004), 20:3n-6 (11 < 0.006). and 22:5n-6 ( y < 0.003) decreased significantly with time while 18:0 ( p < 0.001) and 22:5n-3 ( p < 0.05) increased with time. Despite the decline in DHA in unsupplemented infants, 22:5n-6 did not increase as would have been expected with normal .14-desaturase activity.
A dmini.s/rarion c~f'tnicrodispcrsed,/i.rh oil j.ctudy 2)
. Infants in study 2 had body weights at birth ranging from 560 to 1390 g with means (1SD) in unsupplemented ( n = 6), low fish oilsupplemented (1 I mg/kg/day DHA, 0.2% of fatty acids, n = 4), and high fish oil-supplemented (27 mg/kg/day DHA, 0.5% of total fatty acids. n = 6) of 974 t 300. 932 t 314, and 938 t 98 g. At enrollment infants ranged in age from 14 to 49 days except for one infant in the high supplement group who was 71 days old. The mean age at enrollment was 29 -t 1 l (18-47) days, 28 -t 1 1 (21-44) days, and 41 k 21 (14-49. 71) days for the respective groups. These differences were not significant. Figure 2 indicates the effects of time and the two levels of fish oil supplementation on plasma PE DHA and EPA. Only the formula containing 0.2% DHA at 14 days differed significantly < 0.02: **differs from 0.5% DHA at enrollment, p < 0.01. from cnrollmcnt using the St~rrlcnt'\ / test although the o\c~-all tirnc x 11-catrncnt cfl'cct o n 1' 1 111 IA \\:I\ \lgnificant (11 < 0.02).
[;LIT-1hcrrno1-c. supplcmcntccl (I>otli 0.2 anti 0.5'' 1)IIA) inf~rits h;rd sigr1ific:intly gl-cater 1' 1: I ) I 1A comp:trcd to unsup~>lcrncntcd inli~nts alter-\c\cn alltl I4 <la!\ ol'l'cctiing (11 < 0.05). I he t\\o doses of I l l IA (0.2 or-0.5"; ) lcsultcd in siliiila~-plasma 1' 1. 1>1 1 8 1 .
h:~cl alrcad! incr-casctl signilicantl> h! 74 I1 in tile t\\o lish oil-supplcmcntd gl-o~rpj. 1' 1: Iil'A i l r fish oil-\ul>plcmcntcd irili~nt\ difl'ercd \rgnilicantl! from 0 icnr-ollrncnt) at 1 . 7. and I4 tration could provide long-term maintenance of membrane phospholipid DHA in preterm infants. Long-term studies of DHA function in preterm infants could then be undertaken without undue concern for infants' safety. Measurement of plasma lipid DHA after bolus administration of fish oil, combined with earlier studies of membrane phospholipid DHA in these same infants (3), indicate levels of plasma DHA which prevent declines in membrane phospholipid DHA. Dispersion of fish oil in formula produced equivalent or greater elevations in plasma lipid DHA. Together these observations suggest that declines in membrane phospholipid DHA following preterm delivery may be prevented by prolonged consumption of DHA in amounts typically consumed by infants fed human milk.
Our hypothesis is that preterm infants may require supplemental DHA for normal functional development of the central nervous system and retina. If lesions exist due to inability of the newborn to synthesize DHA from dietary precursors, preterm infants would likely be more vulnerable than term infants. Accordingly, we have undertaken studies in preterm infants with the goal of measuring development of visual acuity in supplemented and unsupplemented infants during infancy.
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